for interspecies differences in mitochondrial toxicity of fialuridine. J Biol Chem
2006.
LeisJ,StepanD,CurtinP,FordJ,PengB,SchubachS,DrukerB,MaziarzR.CentralNervous
System Failure in Patients with Chronic Myelogenous Leukemia Lymphoid Blast Crisis
and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia and Lymphoma
2004; Treated with Imatinib (STI-571). Leukemia– Lymphoma 2004;45(4):695–698.
Leggas M, Panetta JC, Zhuang Y, Schuetz JD, Johnston B, Bai F, Sorrentino B, Zhou
S, Houghton PJ, Stewart CF. Gefitinib modulates the function of multiple ATP-
binding cassette transportersin vivo. Cancer Res 2006;66:4802–4807.
Lessem J, Bellinetto A. Interaction between digoxin and the calcium antagonists
nicardipine and tiapamil. Clin Ther 1983;5:595–602.
Li Q, Sai Y, Kato Y, Tamai I, Tsuji A. Influence of drugs and nutrients on transporter
gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines. Pharm Res
2003;20:1119–1124.
Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: Effect on
serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase
inhibitors. Clin Pharmacol Ther (St. Louis) 1998;64:477–483.
Lilja JJ, Neuvonen M, Neuvonen PJ. Effects of regular consumption of grapefruit juice
on the pharmacokinetics of simvastatin. Br J Clin Pharmacol 2004;58:56–60.
Lindell M, Karlsson MO, Lennernas H, Pahlman L, Lang MA. Variable expression of
CYP and Pgp genes in the human small intestine. Eur J Clin Invest 2003;33:493–499.
List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, Dorr R,
Karanes C, Hynes HE, Doroshow JH, Shurafa M, Appelbaum FR. Benefit of
cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid
leukemia: a Southwest Oncology Group study. Blood 2001;98:3212–3220.
Litman T, Zeuthen T, Skovsgaard T, Stein WD. Competitive, non-competitive and
cooperative interactions between substrates of P-glycoprotein as measured by its
ATPase activity. Biochim Biophys Acta (BBA) – Mol Basis of Disease
1997;1361:169–176.
Liu L, Pang KS. The roles of transporters and enzymes in hepatic drug processing. Drug
Metab Dispos 2005;33:1–9.
Liu X, Lecluyse EL, Brouwer KR, Lightfoot RM, Lee JI, Brouwer KLR. Use of Ca2+
modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes.
J Pharmacol Exp Ther 1999;289:1592–1599.
Loescher W, Potschka H. Role of drug efflux transporters in the brain for drug
disposition and treatment of brain diseases. Prog Neurobiol (Amsterdam,
Netherlands) 2005;76:22–76.
Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P,
Brown MB, Guo W, Rossi SJ, Benet LZ, Watkins PB. Role of intestinal P-
glycoprotein (mdr1) in interpatient variation in the oral bioavailability of
cyclosporine. Clin Pharmacol Ther 1997;62:248–260.
Lu C, Miwa GT, Prakash SR, Gan L-S, Balani SK. A novel model for the prediction of
drug–drug interactions in humans based onin vitrocyp phenotypic data. Drug Metab
Dispos 2007;35:79–85.
Lum B, Kaubisch S, Yahanda A, Adler K, Jew L, Ehsan M, Brophy N, Halsey J, Gosland
M, Sikic B. Alteration of etoposide pharmacokinetics and pharmacodynamics by
REFERENCES 193